Walleye Partners »

Immunitybio shares owned by Walleye Partners

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Walleye Partners from 13F filings

Historical chart of Walleye Partners investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Walleye Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Walleye Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $87k 11k 7.67

More positions owned by Walleye Partners

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Loews Corporation (L)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Meta Platforms Cl A (META)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Howard Hughes Holdings (HHH)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Principal Exchange Traded Prin U S Small (PSC)
Ishares Tr Ibonds Dec 29 (IBDU)
PAR Technology Corporation (PAR)
Apple (AAPL)
Ishares Tr Ibonds 27 Etf (IBDS)
Capital Group International SHS (CGIE)

View all positions for Walleye Partners

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
D. E. Shaw & Co
Geode Capital Management
Susquehanna International
Citadel Advisors
Two Sigma Investments
LMR Partners
Morgan Stanley
Hrt Financial
Woodline Partners
Goldman Sachs Group

View all funds holding Immunitybio